News

News
In the media

Mestag Therapeutics

Read full story
Partner news

Apollo Therapeutics Completes $145 Million Financing Led by Patient Square Capital to Expand and Advance Portfolio-Based Drug Development

Read full story
Partner news

Oxford to collaborate with Janssen to map the cellular landscape of immune mediated disorders

Read full story
Partner news

Exonate announces the initiation of Phase Ib/II clinical trial for Diabetic Macular Oedema, as part of its collaboration with Janssen

Read full story
Partner news

£10 million research collaboration to detect lung cancer earlier

Read full story
Partner news

UK Biobank launches one of the largest scientific studies measuring circulating proteins, to better understand the link between genetics and human disease

Read full story
Partner news

Koa Health to collaborate with Janssen: Official press release

Read full story
Partner news

BaseLaunch announces that Johnson & Johnson Innovation has renewed its commitment becoming latest strategic partner in the second phase

Read full story
In the media

Investing in innovation – new digital approaches for a new decade

Read full story
Partner news

Imec collaborates with Janssen to advance precision medicine to treat and eliminate disease

Read full story
In the media

The Startup Slam, a Highlight at BIO-Europe 2019

Read full story
Partner news

Exonate Announces Collaboration with Janssen to develop a new eye drop for the treatment of retinal vascular diseases including wet age-related macular degeneration (AMD) and diabetic macular oedema (DMO)

Read full story
In the media

At the Bio-Europe conference in Hamburg last month, experts weighed in on the challenges and future of neuroscience

Read full story
In the media

Medopad And Janssen Develop Automated Digital Test To Detect Alzheimer’s Earlier

Read full story
Partner news

Medicines Discovery Catapult, MQ: Transforming mental health and Alzheimer’s Research UK announce an innovative drug discovery consortium with industry, supported by the Wellcome Trust.

Read full story